{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:24:14Z","timestamp":1771550654006,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset Ferring Stiftelsen Handlanden Hjalmar Svenssons","doi-asserted-by":"publisher","award":["ALFGBG-70 940"],"award-info":[{"award-number":["ALFGBG-70 940"]}],"id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset Ferring Stiftelsen Handlanden Hjalmar Svenssons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset Ferring Stiftelsen Handlanden Hjalmar Svenssons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1093\/humrep\/dex012","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T03:31:32Z","timestamp":1486524692000},"page":"811-819","source":"Crossref","is-referenced-by-count":36,"title":["The addition of anti-M\u00fcllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response\u2014a randomized, controlled trial"],"prefix":"10.1093","volume":"32","author":[{"given":"\u00c5.","family":"Magnusson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Oler\u00f6d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thurin-Kjellberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"key\n\t\t\t\t20170320090632_dex012C1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/aogs.12710","article-title":"Comparing four ovarian reserve markers-associations with ovarian response and live births after assisted reproduction","volume":"94","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20170320090632_dex012C3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170320090632_dex012C4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve test and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"on behalf of the IPD-EXPORT Study group","year":"2013","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10815-015-0571-6","article-title":"Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study","volume":"32","year":"2015","journal-title":"J Ass Reprod Genet"},{"key":"key\n\t\t\t\t20170320090632_dex012C7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t20170320090632_dex012C8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1185\/030079906X104678","article-title":"Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients","volume":"22","author":"FSH Treatment Guidelines Clinical Panel","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20170320090632_dex012C9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.fertnstert.2010.03.023","article-title":"Antral follicle count in clinical practice: analyzing clinical relevance","volume":"95","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","year":"2015","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170320090632_dex012C11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-0528.2010.02545.x","article-title":"A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count","volume":"117","year":"2010","journal-title":"BJOG"},{"key":"key\n\t\t\t\t20170320090632_dex012C12","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/humrep\/det303","article-title":"The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China","volume":"28","year":"2013","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-M\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","year":"2010","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170320090632_dex012C15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","year":"2014","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170320090632_dex012C16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.fertnstert.2015.08.014","article-title":"450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial","volume":"104","year":"2015","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fertnstert.2011.05.099","article-title":"How many eggs are needed to produce an assisted reproductive technology baby: is more always better","volume":"96","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","year":"1992","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C19","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C20","first-page":"867","article-title":"Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","year":"2009","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C21","first-page":"411","article-title":"The journey from the old to the new AMH assay: how to avoid getting lost in the values","volume":"23","year":"2011","journal-title":"RBM Online"},{"key":"key\n\t\t\t\t20170320090632_dex012C22","first-page":"923","article-title":"Comparison of anti-M\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","year":"2015","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C23","author":"ESTHER-1","year":"2016"},{"key":"key\n\t\t\t\t20170320090632_dex012C24","first-page":"248","article-title":"Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa","volume":"30","year":"2015","journal-title":"RBM Online"},{"key":"key\n\t\t\t\t20170320090632_dex012C25","year":"2016"},{"key":"key\n\t\t\t\t20170320090632_dex012C26","volume-title":"Clinical Trials: A Practical Approach","year":"1983"},{"key":"key\n\t\t\t\t20170320090632_dex012C27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/humrep\/deg181","article-title":"A prospective study of predictive factors of ovarian response in \u2018standard\u2019 IVF\/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram","volume":"18","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a \u2018standard\u2019 dose of 150 IU\/day in \u2018standard\u2019 patients undergoing IVF\/ICSI treatment","volume":"18","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170320090632_dex012C31","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400135 treatment cycles","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/14.suppl_2.107","article-title":"Ovarian stimulation and endometrial receptivity","volume":"14","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170320090632_dex012C33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170320090632_dex012C34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6874-12-29","article-title":"The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial","volume":"12","year":"2012","journal-title":"BMC Women's Health"},{"key":"key\n\t\t\t\t20170320090632_dex012C35","year":"2016"},{"key":"key\n\t\t\t\t20170320090632_dex012C36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1258\/acb.2011.010172","article-title":"A multicenter evaluation of the new Beckman Coulter antimullerian hormone immunoassay (AMH-Gen II)","volume":"48","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"key\n\t\t\t\t20170320090632_dex012C37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/humrep\/deu036","article-title":"A single-centre evaluation of two new anti-M\u00fcllerian hormone assays and comparison with the current clinical standard assay","volume":"29","year":"2014","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/32\/4\/811\/11032823\/dex012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T14:36:25Z","timestamp":1503585385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/dex012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,8]]},"published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dex012","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}